Zageno key facts
as of Oct 2026- Operator of a life science marketplace intended to simplify the process of providing research scientists with what they need.
- Zageno is valued at approximately $300.0M as of Oct 2026 (last reported valuation).
- It has raised $128.9M across 2 recorded rounds; the latest was Early Stage VC ($8.0M) in Aug 2025.
- Notable investors include FJ Labs, General Catalyst, Capnamic Ventures, Zachary Weinberg, Kaiser Permanente — 12 tracked in total.
- Zageno has filed 2 Form Ds with the SEC since 2017, most recently Aug 2025 ($8.0M sold to 7 investors).
- Status: Privately Held (backing).
Zageno's last reported valuation, Nov 2021. Nothing priced has surfaced since.
- ·The complete investor list: 12 names
- ·Watch Zageno: the Monday email on marks, rounds and moves
Zageno funding rounds
2 roundsWho backs Zageno
12+Zageno valuation
Zageno's last reported valuation was $300 million in Nov 2021. No priced round, secondary trade or fund mark has surfaced since.
How much has Zageno raised?
Zageno has raised $129 million in total; 2 of its rounds are on record. The largest on record was an $8 million early-stage round in Aug 2025.
Zageno has filed 2 Form Ds with the SEC since 2017, most recently in Aug 2025 ($8 million sold to 7 investors).
Zageno investors
12 investors are on record for Zageno, including FJ Labs, General Catalyst, Capnamic Ventures and Zachary Weinberg. The early-stage round in Aug 2025 drew 7 investors.
About Zageno
Operator of a life science marketplace intended to simplify the process of providing research scientists with what they need. The company's marketplace makes online shopping for any research material convenient, and reliable with a product rating system that offers impartial and peer-reviewed ratings, enabling life science researchers to save time and money while making more informed purchasing decisions.
- Sector
- Healthcare
- HQ
- Cambridge, MA, United States
- Founded
- 2015
- Employees
- 155
- Website
- zageno.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.